作者
Zhenqiang Su, Baitang Ning, Hong Fang, Huixiao Hong, Roger Perkins, Weida Tong, Leming Shi
发表日期
2011/4/1
来源
Expert review of molecular diagnostics
卷号
11
期号
3
页码范围
333-343
出版商
Taylor & Francis
简介
DNA sequencing is a powerful approach for decoding a number of human diseases, including cancers. The advent of next-generation sequencing (NGS) technologies has reduced sequencing cost by orders of magnitude and significantly increased the throughput, making whole-genome sequencing a possible way for obtaining global genomic information about patients on whom clinical actions may be taken. However, the benefits offered by NGS technologies come with a number of challenges that must be adequately addressed before they can be transformed from research tools to routine clinical practices. This article provides an overview of four commonly used NGS technologies from Roche Applied Science//454 Life Sciences, Illumina, Life Technologies and Helicos Biosciences. The challenges in the analysis of NGS data and their potential applications in clinical diagnosis are also discussed.
学术搜索中的文章
Z Su, B Ning, H Fang, H Hong, R Perkins, W Tong… - Expert review of molecular diagnostics, 2011